Global Targeted Drugs for Allergic Diseases Competitive Landscape Professional Research Report 2024

Report Format: PDF   |   Report ID: 5685950   |   Published Date: August 2024   |   Pages:  170+  

Research Summary
Targeted drugs for allergic diseases are medications designed to address the underlying causes and mechanisms of allergic reactions with precision. Unlike traditional allergy treatments, which primarily alleviate symptoms, targeted drugs aim to specifically target and modulate the immune response involved in allergic reactions. These drugs work by blocking or modifying specific pathways, molecules, or cells involved in the allergic response, resulting in more effective and tailored treatment approaches. Examples of targeted drugs for allergic diseases include antihistamines, which block the action of histamine, corticosteroids that reduce inflammation, leukotriene modifiers that target inflammatory molecules, and immunomodulators that regulate immune system activity. By targeting specific aspects of the immune response, these drugs offer improved symptom relief, reduced side effects, and better overall management of allergic diseases such as asthma, allergic rhinitis, and atopic dermatitis.
According to DIResearch's in-depth investigation and research, the global Targeted Drugs for Allergic Diseases market size will reach US$ XX Million in 2024, and is expected to reach US$ XX Million in 2030, with a CAGR of XX% (2025-2030). Among them, the China market has changed rapidly in the past few years. The market size in 2024 will be US$ XX Million, accounting for approximately XX% of the world. It is expected to reach US$ XX Million in 2030, and the global share will reach XX%.
The major global manufacturers of Targeted Drugs for Allergic Diseases include Sanofi, Novartis, GSK, Amgen, AstraZeneca, Biosion, Pfizer, UCB, Otsuka Pharmaceutical, Roche, Keymed Biosciences, Mabpharm, Genrix Bio, Dragon Boat Pharmaceutical, Jiangsu Hengrui Pharmaceuticals, Sunshine Guojian, Qyuns Therapeutics etc. The global players competition landscape in this report is divided into three tiers. The first tiers is the global leading enterprise, which occupies a major market share, is in a leading position in the industry, has strong competitiveness and influence, and has a large revenue scale; the second tiers has a certain share and popularity in the market, actively follows the industry leaders in product, service or technological innovation, and has a medium revenue scale; the third tiers has a smaller share in the market, has a lower brand awareness, mainly focuses on the local market, and has a relatively small revenue scale.
This report studies the market size, price trends and future development prospects of Targeted Drugs for Allergic Diseases. Focus on analysing the market share, product portfolio, revenue and gross profit margin of global major manufacturers, as well as the market status and trends of different product types and applications in the global Targeted Drugs for Allergic Diseases market. The report data covers historical data from 2019 to 2023, base year in 2024 and forecast data from 2025 to 2030.
The regions and countries in the report include North America, Europe, China, APAC (excl. China), Latin America and Middle East and Africa, covering the Targeted Drugs for Allergic Diseases market conditions and future development trends of key regions and countries, combined with industry-related policies and the latest technological developments, analyze the development characteristics of Targeted Drugs for Allergic Diseases industries in various regions and countries, help companies understand the development characteristics of each region, help companies formulate business strategies, and achieve the ultimate goal of the company's global development strategy.
The data sources of this report mainly include the National Bureau of Statistics, customs databases, industry associations, corporate financial reports, third-party databases, etc. Among them, macroeconomic data mainly comes from the National Bureau of Statistics, International Economic Research Organization; industry statistical data mainly come from industry associations; company data mainly comes from interviews, public information collection, third-party reliable databases, and price data mainly comes from various markets monitoring database.
Global Key Manufacturers of Targeted Drugs for Allergic Diseases Include:
Sanofi
Novartis
GSK
Amgen
AstraZeneca
Biosion
Pfizer
UCB
Otsuka Pharmaceutical
Roche
Keymed Biosciences
Mabpharm
Genrix Bio
Dragon Boat Pharmaceutical
Jiangsu Hengrui Pharmaceuticals
Sunshine Guojian
Qyuns Therapeutics
Targeted Drugs for Allergic Diseases Product Segment Include:
IL-4R
TSLP
IL-5
JAK
IgE
IL-33
Others
Targeted Drugs for Allergic Diseases Product Application Include:
Atopic Dermatitis
Asthma
Chronic Sinusitis with Nasal Polyps
Chronic Obstructive Pulmonary Disease
Others
Chapter Scope
Chapter 1: Product Research Range, Product Types and Applications, Market Overview, Market Situation and Trends
Chapter 2: Global Targeted Drugs for Allergic Diseases Industry PESTEL Analysis
Chapter 3: Global Targeted Drugs for Allergic Diseases Industry Porter's Five Forces Analysis
Chapter 4: Global Targeted Drugs for Allergic Diseases Major Regional Market Size and Forecast Analysis
Chapter 5: Global Targeted Drugs for Allergic Diseases Market Size and Forecast by Type and Application Analysis
Chapter 6: North America Targeted Drugs for Allergic Diseases Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 7: Europe Targeted Drugs for Allergic Diseases Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 8: China Targeted Drugs for Allergic Diseases Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 9: APAC (Excl. China) Targeted Drugs for Allergic Diseases Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 10: Latin America Targeted Drugs for Allergic Diseases Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 11: Middle East and Africa Targeted Drugs for Allergic Diseases Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 12: Global Targeted Drugs for Allergic Diseases Competitive Analysis of Key Manufacturers (Revenue, Market Share, Regional Distribution and Industry Concentration)
Chapter 13: Key Company Profiles (Product Portfolio, Revenue and Gross Margin)
Chapter 14: Industrial Chain Analysis, Include Raw Material Suppliers, Distributors and Customers
Chapter 15: Research Findings and Conclusion
Chapter 16: Methodology and Data Sources
Table of Contents

1 Targeted Drugs for Allergic Diseases Market Overview

1.1 Product Definition and Statistical Scope

1.2 Targeted Drugs for Allergic Diseases Product by Type

1.2.1 Global Targeted Drugs for Allergic Diseases Market Size by Type, 2023 VS 2024 VS 2030

1.2.2 IL-4R

1.2.3 TSLP

1.2.4 IL-5

1.2.5 JAK

1.2.6 IgE

1.2.7 IL-33

1.2.8 Others

1.3 Targeted Drugs for Allergic Diseases Product by Application

1.3.1 Global Targeted Drugs for Allergic Diseases Market Size by Application, 2023 VS 2024 VS 2030

1.3.2 Atopic Dermatitis

1.3.3 Asthma

1.3.4 Chronic Sinusitis with Nasal Polyps

1.3.5 Chronic Obstructive Pulmonary Disease

1.3.6 Others

1.4 Global Targeted Drugs for Allergic Diseases Market Revenue Analysis (2019-2030)

1.5 Targeted Drugs for Allergic Diseases Market Development Status and Trends

1.5.1 Targeted Drugs for Allergic Diseases Industry Development Status Analysis

1.5.2 Targeted Drugs for Allergic Diseases Industry Development Trends Analysis

2 Targeted Drugs for Allergic Diseases Market PESTEL Analysis

2.1 Political Factors Analysis

2.2 Economic Factors Analysis

2.3 Social Factors Analysis

2.4 Technological Factors Analysis

2.5 Environmental Factors Analysis

2.6 Legal Factors Analysis

3 Targeted Drugs for Allergic Diseases Market Porter's Five Forces Analysis

3.1 Competitive Rivalry

3.2 Threat of New Entrants

3.3 Bargaining Power of Suppliers

3.4 Bargaining Power of Buyers

3.5 Threat of Substitutes

4 Global Targeted Drugs for Allergic Diseases Market Analysis by Regions

4.1 Targeted Drugs for Allergic Diseases Overall Market: 2023 VS 2024 VS 2030

4.2 Global Targeted Drugs for Allergic Diseases Revenue and Forecast Analysis (2019-2030)

4.2.1 Global Targeted Drugs for Allergic Diseases Revenue and Market Share by Region (2019-2024)

4.2.2 Global Targeted Drugs for Allergic Diseases Revenue Forecast by Region (2025-2030)

5 Global Targeted Drugs for Allergic Diseases Market Size by Type and Application

5.1 Global Targeted Drugs for Allergic Diseases Market Size by Type

5.2 Global Targeted Drugs for Allergic Diseases Market Size by Application

6 North America

6.1 North America Targeted Drugs for Allergic Diseases Market Size and Growth Rate Analysis (2019-2030)

6.2 North America Key Manufacturers Analysis

6.3 North America Targeted Drugs for Allergic Diseases Market Size by Type

6.4 North America Targeted Drugs for Allergic Diseases Market Size by Application

6.5 North America Targeted Drugs for Allergic Diseases Market Size by Country

6.5.1 US

6.5.2 Canada

7 Europe

7.1 Europe Targeted Drugs for Allergic Diseases Market Size and Growth Rate Analysis (2019-2030)

7.2 Europe Key Manufacturers Analysis

7.3 Europe Targeted Drugs for Allergic Diseases Market Size by Type

7.4 Europe Targeted Drugs for Allergic Diseases Market Size by Application

7.5 Europe Targeted Drugs for Allergic Diseases Market Size by Country

7.5.1 Germany

7.5.2 France

7.5.3 United Kingdom

7.5.4 Italy

7.5.5 Spain

7.5.6 Benelux

8 China

8.1 China Targeted Drugs for Allergic Diseases Market Size and Growth Rate Analysis (2019-2030)

8.2 China Key Manufacturers Analysis

8.3 China Targeted Drugs for Allergic Diseases Market Size by Type

8.4 China Targeted Drugs for Allergic Diseases Market Size by Application

9 APAC (excl. China)

9.1 APAC (excl. China) Targeted Drugs for Allergic Diseases Market Size and Growth Rate Analysis (2019-2030)

9.2 APAC (excl. China) Key Manufacturers Analysis

9.3 APAC (excl. China) Targeted Drugs for Allergic Diseases Market Size by Type

9.4 APAC (excl. China) Targeted Drugs for Allergic Diseases Market Size by Application

9.5 APAC (excl. China) Targeted Drugs for Allergic Diseases Market Size by Country

9.5.1 Japan

9.5.2 South Korea

9.5.3 India

9.5.4 Australia

9.5.5 Indonesia

9.5.6 Vietnam

9.5.7 Malaysia

9.5.8 Thailand

10 Latin America

10.1 Latin America Targeted Drugs for Allergic Diseases Market Size and Growth Rate Analysis (2019-2030)

10.2 Latin America Key Manufacturers Analysis

10.3 Latin America Targeted Drugs for Allergic Diseases Market Size by Type

10.4 Latin America Targeted Drugs for Allergic Diseases Market Size by Application

10.5 Latin America Targeted Drugs for Allergic Diseases Market Size by Country

10.5.1 Mecixo

10.5.2 Brazil

11 Middle East & Africa

11.1 Middle East & Africa Targeted Drugs for Allergic Diseases Market Size and Growth Rate Analysis (2019-2030)

11.2 Middle East & Africa Key Manufacturers Analysis

11.3 Middle East & Africa Targeted Drugs for Allergic Diseases Market Size by Type

11.4 Middle East & Africa Targeted Drugs for Allergic Diseases Market Size by Application

11.5 Middle East & Africa Targeted Drugs for Allergic Diseases Market Size by Country

11.5.1 Saudi Arabia

11.5.2 South Africa

12 Market Competition by Manufacturers

12.1 Global Targeted Drugs for Allergic Diseases Market Revenue by Key Manufacturers (2020-2024)

12.2 Targeted Drugs for Allergic Diseases Competitive Landscape Analysis and Market Dynamic

12.2.1 Targeted Drugs for Allergic Diseases Competitive Landscape Analysis

12.2.2 Global Key Manufacturers Headquarter and Key Area Sales

12.2.3 Market Dynamic

13 Key Companies Analysis

13.1 Sanofi

13.1.1 Sanofi Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

13.1.2 Sanofi Targeted Drugs for Allergic Diseases Product Portfolio

13.1.3 Sanofi Targeted Drugs for Allergic Diseases Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)

13.2 Novartis

13.2.1 Novartis Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

13.2.2 Novartis Targeted Drugs for Allergic Diseases Product Portfolio

13.2.3 Novartis Targeted Drugs for Allergic Diseases Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)

13.3 GSK

13.3.1 GSK Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

13.3.2 GSK Targeted Drugs for Allergic Diseases Product Portfolio

13.3.3 GSK Targeted Drugs for Allergic Diseases Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)

13.4 Amgen

13.4.1 Amgen Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

13.4.2 Amgen Targeted Drugs for Allergic Diseases Product Portfolio

13.4.3 Amgen Targeted Drugs for Allergic Diseases Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)

13.5 AstraZeneca

13.5.1 AstraZeneca Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

13.5.2 AstraZeneca Targeted Drugs for Allergic Diseases Product Portfolio

13.5.3 AstraZeneca Targeted Drugs for Allergic Diseases Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)

13.6 Biosion

13.6.1 Biosion Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

13.6.2 Biosion Targeted Drugs for Allergic Diseases Product Portfolio

13.6.3 Biosion Targeted Drugs for Allergic Diseases Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)

13.7 Pfizer

13.7.1 Pfizer Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

13.7.2 Pfizer Targeted Drugs for Allergic Diseases Product Portfolio

13.7.3 Pfizer Targeted Drugs for Allergic Diseases Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)

13.8 UCB

13.8.1 UCB Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

13.8.2 UCB Targeted Drugs for Allergic Diseases Product Portfolio

13.8.3 UCB Targeted Drugs for Allergic Diseases Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)

13.9 Otsuka Pharmaceutical

13.9.1 Otsuka Pharmaceutical Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

13.9.2 Otsuka Pharmaceutical Targeted Drugs for Allergic Diseases Product Portfolio

13.9.3 Otsuka Pharmaceutical Targeted Drugs for Allergic Diseases Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)

13.10 Roche

13.10.1 Roche Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

13.10.2 Roche Targeted Drugs for Allergic Diseases Product Portfolio

13.10.3 Roche Targeted Drugs for Allergic Diseases Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)

13.11 Keymed Biosciences

13.11.1 Keymed Biosciences Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

13.11.2 Keymed Biosciences Targeted Drugs for Allergic Diseases Product Portfolio

13.11.3 Keymed Biosciences Targeted Drugs for Allergic Diseases Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)

13.12 Mabpharm

13.12.1 Mabpharm Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

13.12.2 Mabpharm Targeted Drugs for Allergic Diseases Product Portfolio

13.12.3 Mabpharm Targeted Drugs for Allergic Diseases Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)

13.13 Genrix Bio

13.13.1 Genrix Bio Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

13.13.2 Genrix Bio Targeted Drugs for Allergic Diseases Product Portfolio

13.13.3 Genrix Bio Targeted Drugs for Allergic Diseases Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)

13.14 Dragon Boat Pharmaceutical

13.14.1 Dragon Boat Pharmaceutical Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

13.14.2 Dragon Boat Pharmaceutical Targeted Drugs for Allergic Diseases Product Portfolio

13.14.3 Dragon Boat Pharmaceutical Targeted Drugs for Allergic Diseases Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)

13.15 Jiangsu Hengrui Pharmaceuticals

13.15.1 Jiangsu Hengrui Pharmaceuticals Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

13.15.2 Jiangsu Hengrui Pharmaceuticals Targeted Drugs for Allergic Diseases Product Portfolio

13.15.3 Jiangsu Hengrui Pharmaceuticals Targeted Drugs for Allergic Diseases Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)

13.16 Sunshine Guojian

13.16.1 Sunshine Guojian Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

13.16.2 Sunshine Guojian Targeted Drugs for Allergic Diseases Product Portfolio

13.16.3 Sunshine Guojian Targeted Drugs for Allergic Diseases Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)

13.17 Qyuns Therapeutics

13.17.1 Qyuns Therapeutics Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

13.17.2 Qyuns Therapeutics Targeted Drugs for Allergic Diseases Product Portfolio

13.17.3 Qyuns Therapeutics Targeted Drugs for Allergic Diseases Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)

14 Industry Chain Analysis

14.1 Targeted Drugs for Allergic Diseases Industry Chain Analysis

14.2 Targeted Drugs for Allergic Diseases Industry Raw Material and Suppliers Analysis

14.2.1 Upstream Key Raw Material Supply Analysis

14.2.2 Raw Material Suppliers and Contact Information

14.3 Targeted Drugs for Allergic Diseases Typical Downstream Customers

14.4 Targeted Drugs for Allergic Diseases Sales Channel Analysis

15 Research Findings and Conclusion

16 Methodology and Data Source

16.1 Methodology/Research Approach

16.2 Research Scope

16.3 Benchmarks and Assumptions

16.4 Date Source

16.4.1 Primary Sources

16.4.2 Secondary Sources

16.5 Data Cross Validation

16.6 Disclaimer


Name*
Email ID*
Company*
Phone (With Country Code)*
What is/are your question(s)?:

Publisher: DIResearch
Choose License
Related Reports

Why Market Study Report?


  • Best Price for Reports
  • Large Report Database
  • Easily Customize Reports
  • 24/7 Email & Phone Support